JNJ

JOHNSON & JOHNSON

v3.25.1
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 30, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Sales to customers (Note 9) $ 21,893 $ 21,383
Sales to customers percent to sales 100.00% 100.00%
Cost of products sold $ 7,357 $ 6,511
Cost of products sold percent to sales 33.60% 30.40%
Gross profit $ 14,536 $ 14,872
Gross Profit Percent To Sales 66.40% 69.60%
Selling, marketing and administrative expenses $ 5,112 $ 5,257
Selling marketing and administrative expenses percent to sales 23.30% 24.60%
Research and development expense $ 3,225 $ 3,542
Research and development expense percent to sales 14.70% 16.60%
Interest income $ (332) $ (364)
Interest income percent to sales (1.50%) (1.70%)
Interest expense, net of portion capitalized $ 204 $ 155
Interest expense, net of portion capitalized percent to sales 0.90% 0.70%
Other (income) expense, net $ (7,321) $ 2,404
Other (income) expense, net percent to sales (33.40%) 11.20%
Restructuring (Note 12) $ 17 $ 164
Restructuring charge percent to sales 0.10% 0.80%
Earnings before provision for taxes on income $ 13,631 $ 3,714
Earnings before provision for taxes on income percent to sales 62.30% 17.40%
Provision for taxes on income (Note 5) $ 2,632 $ 459
Provision for taxes on income percent to sales 12.10% 2.20%
Net earnings from continuing operations percent of sales 50.20% 15.20%
Net earnings $ 10,999 $ 3,255
NET EARNINGS PER SHARE    
Total net earnings per share - basic (in dollars per share) $ 4.57 $ 1.35
Total net earnings per share - diluted (in dollars per share) $ 4.54 $ 1.34
Avg. shares outstanding    
Basic (shares) 2,407.2 2,408.2
Diluted (shares) 2,423.8 2,430.1